Evidence map›Paper›PMID 38853275›Full record

ArticleStem cell research & therapy2024

Fetal liver CD34

Teja Celhar, Xinyi Li, Yunqian Zhao, Hui Chien Tay, Andrea Lee, Hui Hua Liew, Edwin Kunxiang Shepherdson, Ravisankar Rajarethinam, Yiping Fan, Anselm Mak and 3 more

Abstract read
In one paragraph

Article in Stem cell research & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Endothelial progenitor cells and chronic obstructive pulmonary disease: From basic research to clinical application.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2024
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Teja CelharSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos #04-06, Singapore, 138648, Republic of Singapore. teja_celhar@IDlabs.a-star.edu.sg.ORCID 0000-0003-1384-0941
Xinyi LiSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos #04-06, Singapore, 138648, Republic of Singapore.
Yunqian ZhaoSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos #04-06, Singapore, 138648, Republic of Singapore.
Hui Chien TaySingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos #04-06, Singapore, 138648, Republic of Singapore.
Andrea LeeSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos #04-06, Singapore, 138648, Republic of Singapore.
Hui Hua LiewDepartment of Reproductive Medicine, KK Women's and Children's Hospital, Singapore, 229899, Republic of Singapore.
Edwin Kunxiang ShepherdsonDepartment of Reproductive Medicine, KK Women's and Children's Hospital, Singapore, 229899, Republic of Singapore.
Ravisankar RajarethinamInstitute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore, 138673, Republic of Singapore.
Yiping FanDepartment of Reproductive Medicine, KK Women's and Children's Hospital, Singapore, 229899, Republic of Singapore.
Anselm MakDepartment of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Jerry Kok Yen ChanDepartment of Reproductive Medicine, KK Women's and Children's Hospital, Singapore, 229899, Republic of Singapore.
Amit SinghalSingapore Immunology Network (SIgN), Agency for Science, Technology and Research (A*STAR), 8A Biomedical Grove, Immunos #04-06, Singapore, 138648, Republic of Singapore.
Takeshi TakahashiCentral Institute for Experimental Animals (CIEA), 3-25-12 Tonomachi, Kawasaki-ku, Kawasaki, Kanagawa, 210-0821, Japan.

Funding

Industry Alignment Fund - Pre-positioning Programme (IAF-PP) #H16/01/a0/002National Medical Research Council (SG) CIRG/1484/2018, NMRC CSA (SI)/008/2016, NMRC STaR22jul-0004National Research Foundation (NRF), Immunomonitoring Service Platform (ISP) grant NRF2017_SISFP09Singapore's Ministry of Health MOH-001221-01, MOH-000932-00
6 · The paper itself

Abstract

backgroundTransplantation of CD34

methodsNOG mice were transplanted with either CB-CD34

resultsWe show that CB-CD34

conclusionOur results highlight important phenotypical and functional differences between CB- and FL-NOG and reveal FL-NOG as a potential model to study hepatic sinusoidal dilatation and mechanisms of GVT.

Indexed as

Antigens, CD34LiverAnimalsEndothelial Progenitor CellsFetal BloodHematopoietic Stem CellsHematopoietic Stem Cell TransplantationHumansMelanomaMiceMice, Inbred NODMice, SCIDAntigens, CD34Allogeneic tumor rejectionCord blood CD34Endothelial disfunctionFetal liver CD34Graft-versus-tumorHSPCHumanized miceLSECSinusoidal dilatation

Identifiers

PMID38853275
PMCPMC11163708

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.